News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine – ESMO
Vivek Subbiah/LinkedIn
Mar 5, 2025, 07:35

The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine – ESMO

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

“ESMOTAT25: The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine.

Vivek Subbiah, MD discusses the paradigm shift away, at least partially, from organ-based treatment to molecularly guided treatment across tumour types. He describes how regulatory shifts and greater access to tumour profiling are now needed to realise their full benefits for patients.

To learn more, read the Opinion piece in the ESMO Daily Reporter.”

The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine - ESMO

More posts featuring ESMO.

cancer ESMO ESMO Daily Reporter ESMOTAT25 European Society for Medical Oncology OncoDaily Oncology Precision Medicine Tumour Agnostic Drug Development Vivek Subbiah
Special Coverage
Voices
Aug 24, 2025, 01:32
Minhua Chu: Zelgen Biopharma’s ZGGS34 Gets FDA Approval for Solid Tumor Study
Insight
Aug 24, 2025, 01:13
Discovering Approaches to Enhance CAR-NK Cell Antitumor Activity with CRISPR - MD Anderson Cancer Center
Voices
Aug 23, 2025, 23:27
Lauren Kriger Groner: Filming the Cracking Cancer Podcast with The White Ribbon Project
Voices
Aug 23, 2025, 22:57
Paolo Tarantino: Exploring IO and ADC Combinations at SITC25
Drugs
Aug 23, 2025, 22:35
LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen
Voices
Aug 23, 2025, 22:10
Neeraj Agarwal: USPCCC 2025 with Alan H Bryce's Introductory Remarks
Voices
Aug 23, 2025, 21:58
Al-Ola A Abdallah: Reducing Platelet Transfusion Threshold Before LP in Hematologic Malignancy Patients
Voices
Aug 23, 2025, 21:42
Nina Niu Sanford: NRG-GI011 Has Enrolled and Randomized Its 1st Patient
Voices
Aug 23, 2025, 21:31
Rahul Banerjee Shared NEJM Study on Targeted Therapy of CAR+ T-Cell Lymphoma
Societies
Aug 23, 2025, 20:55
Advancing Cancer Treatment with Therapeutic Vaccines - MSKCC
Voices
Aug 23, 2025, 20:22
Joe Taylor's Last Week in the Lab at Fred Hutch Cancer Center - Hsieh Lab
Voices
Aug 23, 2025, 20:12
Sameer Keole Previews ASTRO25: Rediscovering Radiation Medicine and Exploring New Indications